Journal Mobile Options
Table of Contents
Vol. 15, No. 1, 2009
Issue release date: December 2008
Eur Addict Res 2009;15:25–31

Influence of Personality Disorder Features on Social Functioning in Substance-Abusing Women Five Years after Compulsive Residential Treatment

Jansson I. · Hesse M. · Fridell M.
aDepartment of Psychology, Lund University, Lund, Sweden; bCentre for Alcohol and Drug Research, Copenhagen, Denmark

Individual Users: Register with Karger Login Information

Please create your User ID & Password

Contact Information

I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in


Background: Personality disorders (PD) are related to negative outcome in substance abuse treatment, and in the general population, personality disorders are related to negative outcome in overall functioning. Little is known about the impact of PD on adjustment following substance abuse treatment. Methods: A cohort of 132 women was followed for 5 years after their index treatment episode in compulsory treatment. During treatment, patients were assessed with the SCID-II. At follow-up, patients were administered a timeline follow-back interview covering their functioning, including employment status over the years, and linked with hospital and criminal justice registers. Results: The impact of PD on functioning varied substantially between disorders and outcome domains. Conduct disorder alone was associated with criminal justice involvement, and conduct disorder and avoidant PD features were associated with unemployment. Dependent PD and obsessive-compulsive personality disorder features were positively associated with employment. Borderline PD features were associated with hospital admissions. Discussion: We discuss how strategies associated with various PDs may foster or hinder social adjustment in general and employment patterns in particular.

Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.


  1. Grant BF, Stinson FS, Dawson DA, Chou PS, Ruan WJ, Pickering R: Co-occurrence of 12-month alcohol and drug use disorders and personality disorders in the United States. Results from the National Epidemiologic Survey of Alcohol and Related Conditions. Arch Gen Psychiatry 2004;61:361–368.
  2. Grant BF, Hasin DS, Stinson FS, Dawson DA, Chou SP, Ruan WJ, et al: Prevalence, correlates, and disability of personality disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J Clin Psychiatry 2004;65:948–958.
  3. Ekselius L, Tillfors M, Furmark T, Fredrikson M: Personality disorders in the general population: DSM-IV and ICD-10 defined prevalence as related to sociodemographic profile. Pers Individ Diff 2001;30:311–320.
  4. Samuels J, Eaton WW, Bienvenu OJ, III, Brown CH, Costa PT Jr, Nestadt G: Prevalence of correlates of personality disorders in a community sample. Br J Psychiatry 2002;180:536–542.
  5. Torgersen S, Kringlen E, Cramer V: The prevalence of personality disorders in a community sample. Arch Gen Psychiatry 2001;58:590–596.
  6. Newton-Howes G, Tyrer P, Johnson T: Personality disorder and the outcome of depression: meta-analysis of published studies. Br J Psychiatry 2006;188:13–20.
  7. Bakken K, Landheim AS, Vaglum P: Access Axis I and II disorders as long-term predictors of mental distress: a six-year prospective follow-up of substance-dependent patients. BMC Psychiatry 2007;7:29.
  8. McKay JR, Alterman AI, Cacciola JS, Mulvaney FD, O’Brien CP: Prognostic significance of antisocial personality disorder cocaine-dependent patients entering continuing care. J Nerv Ment Dis 2000;188:287–296.
  9. Kosten TA, KostenTR, Rounsaville BJ: Personality disorders in opiate addicts show prognostic specificity. J Substance Abuse Treatm 1989;6:163–168.
  10. Fridell M, Hesse M, Johnson E: High prognostic specificity of antisocial personality disorder in patients with drug dependence: results from a five-year follow-up. Am J Addict 2006;15:227–232.
  11. Fridell M, Hesse M, Billsten J: Criminal behavior in antisocial substance abusers between five and fifteen years follow-up. Am J Addict 2007;16:10–14.
  12. Vanström LK, Palmgren-Langlet AC, Björk S: SiS statistik år 2003. Stockholm, National Board of Institutional Care, 2004, p 63.
  13. Jenner H, Segraeus V: The Swedish DOC system: an attempt to combine documentation and self-evaluation. Eur Addict Res 2005;11:186–192.
  14. First M, Spitzer R, Gibbon M, Williams J: The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). I. Description. J Pers Disord 1995;9:83–91.

    External Resources

  15. Lenzenweger MF: Stability and change in personality disorder features. Arch Gen Psychiatry 1999;56:1009–1015.
  16. Derogatis LR, Lipman RS, Covi L: SCL-90: an outpatient psychiatric rating scale – preliminary report. Psychopharmacol Bull 1973;9:13–28.
  17. Fridell M, Cesarec Z, Johansson M, Thorsen SM: Swedish norms, standardization and validation of the Symptom Checklist 90. Stockholm, SIS, 2002.
  18. Gueorguieva R, Krystal JH: Move over ANOVA: progress in analyzing repeated-measures data and its reflection in papers published in the Archives of General Psychiatry. Arch Gen Psychiatry 2004;61:310–317.
  19. Hesse M, Vanderplasschen W, Rapp RC, Broekaert E, Fridell M: Case Management for persons with substance use disorders. Cochrane Database Syst Rev 2007;4:CD00626.
  20. Banerjee P, Duggan C, Huband N, Watson N: Brief psychoeducation for people with personality disorder: a pilot study. Psychol Psychother 2006;79:385–394.
  21. Ball SA: Manualized treatment for substance abusers with personality disorders: dual focus schema therapy. Addict Behav 1998;23:883–891.

Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50